|
1.
|
|
10 p, 2.1 MB |
Shared genetic background between children and adults with attention deficit/hyperactivity disorder
/
Rovira, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Demontis, Ditte (Center for Genomics and Personalized Medicine, Aarhus, Denmark) ;
Sánchez-Mora, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Zayats, Tetyana (Broad Institute of MIT, and Harvard. Stanley Center for Psychiatric Research) ;
Klein, Marieke (University Medical Center Utrecht, UMC Utrecht Brain Center, Department of Psychiatry) ;
Mota, Nina Roth (Radboud University Medical Center. Department of Psychiatry, Donders Institute for Brain, Cognition, and Behaviour) ;
Weber, Heike (University Hospital Frankfurt. Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy) ;
Garcia-Martínez, Iris (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pagerols, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vilar-Ribó, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Arribas, Lorena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Richarte, Vanesa (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Corrales, Montserrat (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Fadeuilhe, Christian (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Bosch, Rosa (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Martin, Gemma Español (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Almos, Peter (University of Würzburg. Division of Molecular Psychiatry, Center of Mental Health) ;
Doyle, Alysa E. (Harvard Medical School. Department of Psychiatry) ;
Grevet, Eugenio Horacio (Universidade Federal do Rio Grande do Sul. Department of Psychiatry, Faculty of Medicine) ;
Grimm, Oliver (University Hospital Frankfurt. Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy) ;
Halmøy, Anne (Haukeland University Hospital. Division of Psychiatry) ;
Hoogman, Martine (Radboud University Medical Center. Department of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour) ;
Hutz, Mara (Universidade Federal do Rio Grande do Sul. Department of Genetics, Institute of Biosciences) ;
Jacob, Christian P. (University of Würzburg. Division of Molecular Psychiatry, Center of Mental Health) ;
Kittel-Schneider, Sarah (University Hospital Frankfurt. Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy) ;
Knappskog, Per M. (University of Bergen. Department of Clinical Science) ;
Lundervold, Astri J. (University of Bergen. Department of Biological and Medical Psychology) ;
Rivero, Olga (University of Würzburg. Division of Molecular Psychiatry, Center of Mental Health) ;
Rovaris, Diego Luiz (University of São Paulo. Department of Physiology and Biophysics, Institute of Biomedical Sciences) ;
Salatino-Oliveira, Angelica (Universidade Federal do Rio Grande do Sul. Department of Genetics, Institute of Biosciences) ;
da Silva, Bruna Santos (Universidade Federal do Rio Grande do Sul. Department of Genetics, Institute of Biosciences) ;
Svirin, Evgeniy (IM Sechenov First Moscow State Medical University. Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine) ;
Sprooten, Emma (Radboud University Medical Centre. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour) ;
Strekalova, Tatyana (Maastricht University. Department of Neuroscience, School for Mental Health and Neuroscience (MHeNS)) ;
Arias-Vasquez, Alejandro (Radboud University Medical Center. Department of Psychiatry, Donders Institute for Brain, Cognition, and Behaviour) ;
Sonuga-Barke, Edmund J. S. (Aarhus University. Department of Child and Adolescent Psychiatry) ;
Asherson, Philip (King's College London. Social Genetic and Developmental Psychiatry, Institute of Psychiatry Psychology and Neuroscience) ;
Bau, Claiton Henrique Dotto (Universidade Federal do Rio Grande do Sul. Department of Genetics, Institute of Biosciences) ;
Buitelaar, Jan K. (Karakter Child and Adolescent Psychiatry, Nijmegen, The Netherlands) ;
Cormand, Bru (Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Catalonia Spain) ;
Faraone, Stephen V. (SUNY Upstate Medical University. Departments of Psychiatry, of Neuroscience, and Physiology) ;
Haavik, Jan (Haukeland University Hospital. Division of Psychiatry) ;
Johansson, Stefan E. (University of Bergen. Department of Clinical Science) ;
Kuntsi, Jonna (King's College London. Social Genetic and Developmental Psychiatry, Institute of Psychiatry Psychology and Neuroscience) ;
Larsson, Henrik (Karolinska Institutet. Department of Medical Epidemiology and Biostatistics) ;
Lesch, Klaus-Peter (Maastricht University. Department of Neuroscience, School for Mental Health and Neuroscience (MHeNS)) ;
Reif, Andreas (University Hospital Frankfurt. Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy) ;
Rohde, Luis Augusto (Federal University of Rio Grande do Sul. Division of Child Psychiatry, Hospital de Clinicas de Porto Alegre) ;
Casas, Miquel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Børglum, Anders D. (Center for Genomics and Personalized Medicine, Aarhus, Denmark) ;
Franke, Barbara (Radboud University Medical Center. Department of Psychiatry, Donders Institute for Brain, Cognition, and Behaviour) ;
Ramos-Quiroga, Josep Antoni (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Soler Artigas, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ribasés, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. [...]
2020 -  10.1038/s41386-020-0664-5
Neuropsychopharmacology, Vol. 45 (april 2020) , p. 1617-1626
|
|
|
2.
|
|
30 p, 2.0 MB |
Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan
/
Franke, Barbara (Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands) ;
Michelini, Giorgia (King's College London, Institute of Psychiatry, Psychology & Neuroscience, Social, Genetic & Developmental Psychiatry Centre, London, UK) ;
Asherson, Philip (King's College London, Institute of Psychiatry, Psychology & Neuroscience, Social, Genetic & Developmental Psychiatry Centre, London, UK) ;
Banaschewski, Tobias (Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany) ;
Bilbow, Andrea (ADHD-Europe, Brussels, Belgium) ;
Buitelaar, Jan K. (Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Cognitive Neuroscience, Nijmegen, The Netherlands) ;
Cormand, Bru (Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Catalonia, Spain) ;
Faraone, Stephen V. (K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway) ;
Ginsberg, Ylva (Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden) ;
Haavik, Jan (Division of Psychiatry, Haukeland University Hospital, Bergen, Norway) ;
Kuntsi, Jonna (King's College London, Institute of Psychiatry, Psychology & Neuroscience, Social, Genetic & Developmental Psychiatry Centre, London, UK) ;
Larsson, Henrik (Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden) ;
Lesch, Klaus-Peter (Department of Translational Neuroscience, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands) ;
Ramos-Quiroga, J. Antoni (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Réthelyi, János M. (MTA-SE NAP-B Molecular Psychiatry Research Group, Hungarian Academy of Sciences, Budapest, Hungary) ;
Ribases, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reif, Andreas (Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany)
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. [...]
2018 - 10.1016/j.euroneuro.2018.08.001
European Neuropsychopharmacology, Vol. 28 (october 2018) , p. 1059-1088
|
|
|
3.
|
|
9 p, 1001.1 KB |
Agonist and antagonist effects of aripiprazole on D2-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone
/
Ma, Guo Fen (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ;
Raivio, Noora (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ;
Sabrià i Pau, Josefa (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ;
Ortiz de Pablo, Jordi (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Background: The atypical antipsychotic drug aripiprazole binds with high affinity to a number of G protein coupled receptors, including dopamine D2 receptors, where its degree of efficacy as a partial agonist remains controversial. [...]
2014 - 10.1093/ijnp/pyu046
International journal of neuropsychopharmacology, Vol. 18, Núm. 4 (february 2015) , p. 1-9
|
|
|
4.
|
|
22 p, 165.0 KB |
D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus
/
Portero Tresserra, Marta (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ;
Olmo Izquierdo, Nuria del (Universidad CEU San Pablo. Departamento de Ciencias Farmacéuticas y de la Salud) ;
Martí Nicolovius, Margarita (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ;
Guillazo i Blanch, Gemma (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ;
Vale Martínez, Anna (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut)
Previous research has demonstrated that systemic D-cycloserine (DCS), a partial agonist of the N-methyl-D-aspartate receptor (NMDAR), enhances memory processes in different learning paradigms and attenuates mnemonic deficits produced by diverse pharmacological manipulations. [...]
2014 - 10.1016/j.euroneuro.2014.10.002
European neuropsychopharmacology, Vol. 24 núm. 11 (2014) , p. 1798-1807
|
|
|
5.
|
|
14 p, 13.3 MB |
Assessing the Psychedelic "After-Glow" in Ayahuasca Users : Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities
/
Riba Serrano, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Sampedro, Frederic (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Vilà-Canet, G. (ICATME, Institut Universitari Quirón-Dexeus, Barcelona, Spain) ;
de la Fuente Revenga, Mario (Institut d'Investigació Biomèdica Sant Pau) ;
Valle, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Roberto, Natalia (Institut d'Investigació Biomèdica Sant Pau) ;
Domínguez-Clavé, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ;
Elices, Matilde (Institut d'Investigació Biomèdica Sant Pau) ;
Luna, Luís Eduardo (Institut d'Investigació Biomèdica Sant Pau) ;
Crippa, José Alexandre S (Institut d'Investigació Biomèdica Sant Pau) ;
Hallak, Jaime E C (Institut d'Investigació Biomèdica Sant Pau) ;
de Araujo, Draulio B (Institut d'Investigació Biomèdica Sant Pau) ;
Friedlander, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Barker, Steven A (Institut d'Investigació Biomèdica Sant Pau) ;
Álvarez, Enrique (Álvarez Martínez) (Institut d'Investigació Biomèdica Sant Pau) ;
Soler, Joaquim (Soler Ribaudi) (Institut d'Investigació Biomèdica Sant Pau) ;
Pascual, Juan C (Institut d'Investigació Biomèdica Sant Pau) ;
Feilding, Amanda (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Ayahuasca is a plant tea containing the psychedelic 5-HT agonist N,N -dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. [...]
2017 - 10.1093/ijnp/pyx036
International journal of neuropsychopharmacology, Vol. 20 (june 2017) , p. 698-711
|
|
|
6.
|
|
12 p, 1.2 MB |
Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
/
Udina, M (Department of Psychiatry, Hospital Clínic, Institut d'Investigacions Biomèdiques de Barcelona (IDIBAPS)) ;
Navinés, Ricard (Parc de Salut Mar. Secció Hepàtica) ;
Egmond, E ;
Oriolo, G ;
Langohr, K ;
Gimenez, D (Parc de Salut Mar. Secció Hepàtica) ;
Valdés, M ;
Gómez-Gil, E ;
Grande, I ;
Gratacòs i Mayora, Mònica ;
Kapczinski, F ;
Artigas, F ;
Vieta, E ;
Solà, R (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Martín-Santos, R ;
Universitat Autònoma de Barcelona
The role of inflammation in mood disorders has received increased attention. There is substantial evidence that cytokine therapies, such as interferon alpha (IFN-alpha), can induce depressive symptoms. [...]
2015 - 10.1093/ijnp/pyv135
International journal of neuropsychopharmacology, Vol. 19 (december 2015)
|
|
|
7.
|
|
12 p, 168.5 KB |
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
/
Alvarez, Enric (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Perez, Victor (Ministry of Science and Innovation (CIBERSAM)) ;
Dragheim, Marianne (H. Lundbeck A/S, Copenhagen, Denmark) ;
Loft, Henrik (H. Lundbeck A/S, Copenhagen, Denmark) ;
Artigas, Francesc (Institut d'Investigacions Biomediques de Barcelona, CSIC, Barcelona, Spain)
The efficacy, safety, and tolerability of Lu AA21004 vs. placebo using venlafaxine XR as active reference in patients with DSM-IV-TR major depressive disorder (MDD) were evaluated. Lu AA21004 is a novel antidepressant that is a 5-HT and 5-HT receptor antagonist, 5-HT receptor agonist, 5-HT receptor partial agonist and inhibitor of the 5-HT transporter in recombinant cell lines. [...]
2011 - 10.1017/S1461145711001027
International journal of neuropsychopharmacology, Vol. 15 (july 2011) , p. 589-600
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
